[Basic fibroblast growth factor (bFGF) and wound healing: a multi-centers and controlled clinical trial in 1024 cases].
To evaluate the effects of bFGF on wound healing and the side-effects of bFGF, a multi-centers and controlled clinical trial were carried out in 32 hospitals in China. One thousand and twenty-four cases with acute wounds such as burn, donor site or operative wound and chronic wounds such as bed sore, draining sinus, ulcer were treated with bFGF. Another 826 cases with the similar wounds were used as control. The results showed: 1. The duration of wound healing was shorted 3-4 days in trial group when compared with the contorl; 2. The successful rates from bFGF on promoting the wound healing for burns, operative wounds and chronic dermal ulcers was 95.2%, 96.5% and 93.5%, respectively; 3. No adverse reaction was found.


CONCLUSIONS
1. bEGF can make the "silent" reparative cells dividing and proliferating. 2. bFGF can improve the quality and the velocity of wound healing.
Fu
X
X
The 304th Hospital of PLA, Beijing, P.R. China.
Shen
Z
Z
Chen
Y
Y
D000287:Administration, Topical; D002056:Burns / Q000188:drug therapy* / Q000503:physiopathology; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D006801:Humans; D003668:Pressure Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D014945:Wound Healing / Q000187:drug effects*
D016222:Fibroblast Growth Factor 2